Medicure Inc. (CVE:MPH – Get Free Report) traded down 1% during trading on Wednesday . The stock traded as low as C$0.98 and last traded at C$0.98. 1,000 shares traded hands during trading, a decline of 79% from the average session volume of 4,731 shares. The stock had previously closed at C$0.99.
Medicure Stock Performance
The stock has a market cap of C$10.23 million, a P/E ratio of -3.92 and a beta of 0.90. The company has a fifty day moving average price of C$0.93 and a 200 day moving average price of C$1.01. The company has a debt-to-equity ratio of 2.06, a current ratio of 1.87 and a quick ratio of 1.29.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Tesla Poised to Hit Record Highs This Holiday Season
- How to trade using analyst ratings
- The Salesforce Rally is Just Getting Started: Here’s Why
- What is a Stock Market Index and How Do You Use Them?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
